COMMUNIQUÉS West-GlobeNewswire
-
Neutrolis Announces New England Journal of Medicine Publication Demonstrating First Clinical Evidence for NET-Degrading Therapy in Severe, Treatment-Refractory Systemic Lupus Erythematosus (SLE) Caused by DNASE1L3 Deficiency
15/07/2026 -
Surrozen to Present at Upcoming Healthcare Investor Conference
15/07/2026 -
Artificial Organs Publishes Independent Commentary on Picard Medical and SynCardia's Emperor Total Artificial Heart Program
15/07/2026 -
Cytek® Biosciences Opens New Innovation Center in Bellevue to Advance R&D and Customer Engagement
15/07/2026 -
Rakovina Therapeutics Announces $1.5 Million Private Placement
15/07/2026 -
PacBio to Report Second Quarter 2026 Financial Results on August 5, 2026
15/07/2026 -
RxSight Announces Appointments of Aziz Mottiwala as Chief Executive Officer and Ron Kurtz, M.D. as Chief Medical Officer
15/07/2026 -
Hyperion DeFi Enters Agreement with Skew Technologies to Launch HIP-3 Perpetual Futures Market and Listing Service
15/07/2026 -
At 68, Nutrition World Founder Edward Jones Returns to the Bodybuilding Stage and Challenges Assumptions About Aging
15/07/2026 -
Rainwater Drake Dental Announces Name Change From Hawkins Rainwater Dental Group
15/07/2026 -
Sinopia Biosciences Publishes Preclinical Data in Science Translational Medicine Supporting SB-0110, a Novel PKA-II Modulator, for Parkinson's Disease
15/07/2026 -
RadioMedix Appoints Brian A. Markison to Board of Directors
15/07/2026 -
Cosmos Health Share Buyback Surpasses 4.5 Million Shares; Continues Open Market Repurchases
15/07/2026 -
IPSEN - Achats effectués dans les conditions de l'Article 5 du Règlement MAR - Semaine xx - 2025
15/07/2026 -
Nadia Care Named ACAP Preferred Vendor, Scaling Community-Centered, Culturally-Informed Care to Combat the Maternal Health Crisis
15/07/2026 -
Inteleos Names First Chief Product Officer to Lead New Healthcare Innovation Division
15/07/2026 -
Novo Nordisk receives European Commission approval of Wegovy® pill as first oral GLP-1 for weight management in the EU; single, ready-to-use pen for higher dose 7.2 mg also approved
15/07/2026 -
IPSEN - Buy-back programme - Art 5 of MAR - Week 28 - 2026
15/07/2026 -
TobaGrown Acquires Manitoba Cannabis Extract Brands HWY 59 and Banter
15/07/2026
Pages